|
Volumn 34, Issue 2, 2004, Pages 265-276
|
Development and validation of a reversed-phase liquid chromatographic method for analysis of degradation products of estradiol in Vagifem® tablets
|
Author keywords
Degradation products; Estradiol; Pharmaceutical analysis; Placebo interference; Reverse phase chromatography; Sample preparation; Stability indicating
|
Indexed keywords
16 KETO 17BETA ESTRADIOL;
4 METHYL 17BETA ESTRADIOL;
6 DEHYDRO 17BETA ESTRADIOL;
6 KETO 17BETA ESTRADIOL;
6 KETOESTRONE;
6ALPHA HYDROXY 17BETA ESTRADIOL;
6BETA HYDROXY 17BETA ESTRADIOL;
ALPHA 17BETA ESTRADIOL;
BETA EQUILENOL;
DRUG METABOLITE;
ESTRADIOL;
ESTRONE;
PLACEBO;
UNCLASSIFIED DRUG;
ACCURACY;
ARTICLE;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
REVERSED PHASE LIQUID CHROMATOGRAPHY;
TABLET FORMULATION;
VALIDATION PROCESS;
|
EID: 0842330582
PISSN: 07317085
EISSN: None
Source Type: Journal
DOI: 10.1016/S0731-7085(03)00501-6 Document Type: Article |
Times cited : (24)
|
References (12)
|